By SHARON LEM, SUN MEDIA
Wes Laporte just graduated from high school and was training to become an Olympic weightlifter when his world started to unravel in June.
The 18-year-old student from Belle River, Ont., near Windsor, was accepted by Dalhousie University to study kinesiology when doctors diagnosed him with myleodysplastic syndrome (MDS) — a blood disease causes ineffective production of blood cells that can turn into cancer.
He was told he needed a bone marrow transplant.
“It didn’t really bother me until I couldn’t do anything. I’m not able to do any physical activity, so it sucks,” Laporte said.
Laporte’s family was not a match. His best chance of finding a match would come from someone of French-Canadian and British ancestry. However, the odds of finding a match are one in 5,000.
“Unless you’re in a family that’s directly affected, the odds are you won’t be tested for the registry because you don’t really realize how much someone needs a bone marrow match,” Laporte said.
He is now receiving three blood transfusions a week. For the past few weeks, Laporte has been travelling to the Michigan Cancer Center in Rochester, Mich., to receive the drug Vidaza, which is not available in Canada.
Ecumedical Resources International is paying for Laporte’s Michigan treatment of $50,000 to $75,000 for four months.
Ecumedical is a charity which helps Canadians to find medical care in the U.S.
For information on becoming a donor, go to onematch.ca or call Canadian Blood Services at 1-888-236-6283.
SHARON.LEM@SUNMEDIA.CA